KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Nektar Therapeutics (NKTR) Interest Coverage Ratio (2016 - 2020)

Historic Interest Coverage Ratio for Nektar Therapeutics (NKTR) over the last 11 years, with Q2 2020 value amounting to 120.11.

  • Nektar Therapeutics' Interest Coverage Ratio fell 46616.91% to 120.11 in Q2 2020 from the same period last year, while for Mar 2021 it was 619.59, marking a year-over-year decrease of 294855.81%. This contributed to the annual value of 62.05 for FY2020, which is 20050.01% down from last year.
  • Latest data reveals that Nektar Therapeutics reported Interest Coverage Ratio of 120.11 as of Q2 2020, which was down 46616.91% from 21.54 recorded in Q1 2020.
  • Nektar Therapeutics' Interest Coverage Ratio's 5-year high stood at 180.8 during Q2 2018, with a 5-year trough of 120.11 in Q2 2020.
  • Moreover, its 5-year median value for Interest Coverage Ratio was 13.16 (2017), whereas its average is 7.09.
  • As far as peak fluctuations go, Nektar Therapeutics' Interest Coverage Ratio crashed by 597731.16% in 2016, and later skyrocketed by 206659.79% in 2018.
  • Quarter analysis of 5 years shows Nektar Therapeutics' Interest Coverage Ratio stood at 5.79 in 2016, then increased by 26.33% to 4.27 in 2017, then plummeted by 334.1% to 18.52 in 2018, then decreased by 9.05% to 20.2 in 2019, then tumbled by 494.63% to 120.11 in 2020.
  • Its Interest Coverage Ratio stands at 120.11 for Q2 2020, versus 21.54 for Q1 2020 and 20.2 for Q4 2019.